(Q48257647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

0 references

0 references

0 references

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fabian Docagne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Cristina Benito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Juan Pablo Romero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rosa María Tolón

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Cecilia J Hillard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Camen Guaza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Julián Romero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

2396-2402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue

26 December 2019

cites work

1 reference

12 December 2020

Pathogenesis of tissue injury in MS lesions

1 reference

12 December 2020

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

12 December 2020

1 reference

12 December 2020

The oligodendrocyte precursor cell in health and disease

1 reference

12 December 2020

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

1 reference

12 December 2020

Antigen retrieval techniques: current perspectives.

1 reference

12 December 2020

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

1 reference

12 December 2020

Cannabinoids and brain injury: therapeutic implications

1 reference

12 December 2020

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

12 December 2020

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

12 December 2020

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

12 December 2020

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study

1 reference

12 December 2020

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes

1 reference

12 December 2020

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

1 reference

12 December 2020

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

1 reference

12 December 2020

Determination of the sequential degradation of myelin proteins by macrophages

1 reference

12 December 2020

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

1 reference

12 December 2020

Emerging properties of cannabinoid medicines in management of multiple sclerosis

1 reference

12 December 2020

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

1 reference

12 December 2020

The endocannabinoid signalling system: biochemical aspects

1 reference

12 December 2020

Functional neuroanatomy of the endocannabinoid system

1 reference

12 December 2020

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

12 December 2020

Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists

1 reference

12 December 2020

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

1 reference

12 December 2020

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

1 reference

12 December 2020

Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.

1 reference

12 December 2020

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

1 reference

12 December 2020

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

12 December 2020

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

1 reference

12 December 2020

Multiple sclerosis--the plaque and its pathogenesis

1 reference

12 December 2020

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

Search for endogenous ligands of the cannabinoid receptor

1 reference

12 December 2020

Macrophages in multiple sclerosis

1 reference

12 December 2020

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

12 December 2020

1 reference

12 December 2020

10.1523/JNEUROSCI.4814-06.2007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329437%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference